Detalhe da pesquisa
1.
Combined Lanreotide Autogel and Temozolomide Treatment of Progressive Pancreatic and Intestinal Neuroendocrine Tumors: The Phase II SONNET Study.
Oncologist
; 29(5): e643-e654, 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38206830
2.
Changes in tumor-to-blood ratio as a prognostic marker for progression-free survival and overall survival in neuroendocrine tumor patients undergoing PRRT.
Eur J Nucl Med Mol Imaging
; 51(3): 841-851, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37947848
3.
Bone Metastases in Patients with Pancreatic NETs: Prevalence and Prognosis.
Horm Metab Res
; 55(12): 827-834, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37611636
4.
Sunitinib-Induced Hypothyroidism and Survival in Pancreatic Neuroendocrine Tumors.
Horm Metab Res
; 53(12): 794-800, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34891209
5.
Treatment-related changes in neuroendocrine tumors as assessed by textural features derived from 68Ga-DOTATOC PET/MRI with simultaneous acquisition of apparent diffusion coefficient.
BMC Cancer
; 20(1): 326, 2020 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32299391
6.
Everolimus in Neuroendocrine Tumors of the Gastrointestinal Tract and Unknown Primary.
Neuroendocrinology
; 106(3): 211-220, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-28554173
7.
Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 18(10): 1411-1422, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28838862
8.
Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study.
Lancet
; 387(10022): 968-977, 2016 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26703889
9.
Evaluation of 68Ga-DOTATOC PET/MRI for whole-body staging of neuroendocrine tumours in comparison with 68Ga-DOTATOC PET/CT.
Eur Radiol
; 27(10): 4091-4099, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28439648
10.
Consanguineous couple with SDHD gene mutations: Diagnosis, treatment, and implications of family genetic testing.
Clin Case Rep
; 12(4): e8572, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38585582
11.
NET-Induced Carcinoid Heart Disease Affecting Both Tricuspid and Aortic Valves Due to Patent Foramen Ovale and Right/Left Shunt: A Multi-imaging Challenge to Nuclear Medicine.
Clin Nucl Med
; 49(2): 157-159, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38178372
12.
Differential uptake of (68)Ga-DOTATOC and (68)Ga-DOTATATE in PET/CT of gastroenteropancreatic neuroendocrine tumors.
Recent Results Cancer Res
; 194: 353-71, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-22918768
13.
Hedinger Syndrome-Lessons Learnt: A Single-Center Experience.
J Cardiovasc Dev Dis
; 10(10)2023 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37887860
14.
Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy.
J Cancer Res Clin Oncol
; 149(8): 4315-4325, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36071236
15.
Outcome of immunotherapy in adrenocortical carcinoma: a retrospective cohort study.
Eur J Endocrinol
; 188(6): 485-493, 2023 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37260092
16.
[Oncological theranostics in nuclear medicine]. / Onkologische Theranostik in der Nuklearmedizin.
Radiologie (Heidelb)
; 62(10): 875-884, 2022 Oct.
Artigo
em Alemão
| MEDLINE | ID: mdl-36112174
17.
CT-derived body composition analysis could possibly replace DXA and BIA to monitor NET-patients.
Sci Rep
; 12(1): 13419, 2022 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35927564
18.
Treatment Approaches and Outcome of Patients with Neuroendocrine Neoplasia Grade 3 in German Real-World Clinical Practice.
Cancers (Basel)
; 14(11)2022 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35681701
19.
Streptozocin/5-fluorouracil chemotherapy of pancreatic neuroendocrine tumours in the era of targeted therapy.
Endocrine
; 75(1): 293-302, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34480724
20.
90Y Radioembolization in the Treatment of Neuroendocrine Neoplasms: Results of an International Multicenter Retrospective Study.
J Nucl Med
; 63(5): 679-685, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34475236